A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitro

Acta Biologica Hungarica

Volumn 53, Issue 3, 2002, Pages 307-315

  Polgár, Anna ^a   Brózik, Márta ^b   Tóth, Sára ^b   Holub, Marcsilla ^b   Falus, A ^b  

^a NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Dexamethasone; Rheumatoid arthritis (RA); Soluble interleukin 6 receptor (sIL 6R); Systemic lupus erythematosus (SLE)

Indexed keywords

BASE SEQUENCE; DEXAMETHASONE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; IN VITRO; LYMPHOCYTES; MALE; RECEPTORS, INTERLEUKIN-6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; GLUCOCORTICOIDS; HUMANS;

DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PRIMER DNA;

ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; LYMPHOCYTE; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036024920     PISSN: 02365383     EISSN: None     Source Type: Journal    
DOI: 10.1556/ABiol.53.2002.3.7     Document Type: Article

References (28)

1. Measurement of gene expression by multiplex competitive polymerase chain reaction
2. The ARA 1987. Revised criteria for the classification of rheumatoid arthritis
3. Derivation of the SLEDAI: A disease activity index for lupus patients
4. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
5. Dissimilar biosynthesis of IL-6 by different areas of synovial membrane of patients with rheumatoid arhritis and osteoarthritis
6. Increased and highly stable levels of functional soluble IL-6R in sera of patients with monoclonal gammopathy
7. Disease severity in patients with SLE correlates with an increased ratio of IL-10: IFN-gamma-secreting cells in the peripheral blood
8. Signal transduction through gp-130 is shared among the receptors for the interleukin-6 related cytokine subfamily
9. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease
10. Generation of "truncated" interlenkin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R
11. Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection
12. IL-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
13. Soluble interleukin-6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes
14. Soluble interlenkin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production
15. Increased osteoclast development after estrogen loss: Mediation by IL-6
16. The biology of interleukin-6
17. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: Analysis of IL-6 production and IL-6R expression
18. Impaired immune and acute phase responses in IL-6 deficient mice
19. Cytokine receptors and signal transduction
20. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with SLE
21. Upregulation of cytokine receptors sTNF-R55, sTNF-R75 and sIL-2R in psoriatic arthritis synovial fluid
22. The function of the soluble IL-6 receptor in vivo sensitisation of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
23. Soluble interleukin-6 receptor (sIL-6R) levels in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)
24. Decrease of IL-6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs
25. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus
26. Gp130 and the interleukin-6 family of cytokines
27. Revised criteria for the classification of systemic lupus erythematosus
28. Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases